Reduced EGFR signaling enhances cartilage destruction in a mouse osteoarthritis model

Bone Research

Volumn 2, Issue , 2014, Pages

  Zhang, Xianrong ^a,b   Zhu, Ji ^a,c   Liu, Fei ^a,d   Li, Yumei ^f   Chandra, Abhishek ^a   Levin, L Scott ^a   Beier, Frank ^e   Enomoto Iwamoto, Motomi ^a,f   Qin, Ling ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WUHAN UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e WESTERN UNIVERSITY   (Canada)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990974624     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2014.15     Document Type: Article

References (42)

1. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann NY Acad Sci 2010; 1192: 230-237.
2. Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int J Mol Sci 2013; 14: 19805-19830.
3. Zhang X, Siclari VA, Lan S, et al. The critical role of the epidermal growth factor receptor in endochondral ossification. J Bone Miner Res 2011; 26: 2622-2633.
4. Usmani SE, Pest MA, Kim G, Ohora SN, Qin L, Beier F. Transforming growth factor alpha controls the transition from hypertrophic cartilage to bone during endochondral bone growth. Bone 2012; 51: 131-141.
5. WangK, Yamamoto H, Chin JR, Werb Z, Vu TH. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem 2004; 279: 53848-53856.
6. Zhang X, Zhu J, Li Y, et al. Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through betacatenin-dependent and-independent pathways. J Biol Chem 2013; 288: 32229-32240.
7. Sahin U, Weskamp G, Kelly K, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779.
8. Hall KC, Hill D, Otero M, et al. ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes. Mol Cell Biol 2013; 33: 3077-3090.
9. Saito K, HoriuchiK, Kimura T, et al. Conditional inactivation ofTNFalphaconverting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. PLoS One 2013; 8: E54853.
10. Appleton CT, Pitelka V, Henry J, Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007; 56: 1854-1868.
11. Appleton CT, Usmani SE, Bernier SM, Aigner T, Beier F. Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum 2007; 56: 3693-3705.
12. Shepard JB, Jeong JW, Maihle NJ, O'Brien S, Dealy CN. Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo. Arthritis Res Ther 2013; 15: R60.
13. Staal B, Williams BO, Beier F, Vande Woude GF, Zhang YW. Cartilagespecific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation. Proc Natl Acad Sci USA 2014; 111: 2590-2595.
14. Zhang YW, Su Y, Lanning N, et al. Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. Proc Natl Acad Sci USA 2005; 102: 11740-11745.
15. Little CB, Barai A, Burkhardt D, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009; 60: 3723-3733.
16. Wang M, Sampson ER, Jin H, et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther 2013; 15: R5.
17. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007; 15: 1061-1069.
18. Lee D, Cross SH, Strunk KE, et al. Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor. Mamm Genome 2004; 15: 525-536.
19. Ma HL, Blanchet TJ, Peluso D, Hopkins B, Morris EA, Glasson SS. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage 2007; 15: 695-700.
20. Aigner T, Cook JL, Gerwin N, et al. Histopathology atlas of animal model systems-overview of guiding principles. Osteoarthritis Cartilage 2010; 18(Suppl 3): S2-S6.
21. Chandra A, Lan S, Zhu J, Siclari V, Qin L. Epidermal Growth Factor Receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing Early Growth Response Protein (Egr2) expression. J Biol Chem 2013; 288: 20488-20498.
22. Harari PM, Allen GW, Bonner JA. Biology of interactions: Antiepidermal growth factor receptor agents. J Clin Oncol 2007; 25: 4057-4065.
23. Zhang X, Tamasi J, Lu X, et al. Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo. J BoneMiner Res 2011; 26: 1022-1034.
24. Sharif M, Whitehouse A, Sharman P, Perry M, Adams M. Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 2004; 50: 507-515.
25. Thomas CM, Fuller CJ, Whittles CE, Sharif M. Chondrocyte death by apoptosis is associated with the initiation and severity of articular cartilage degradation. Int J Rheum Dis 2011; 14: 191-198.
26. D'Lima D, Hermida J, Hashimoto S, Colwell C, Lotz M. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum 2006; 54: 1814-1821.
27. Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs 2003; 174: 34-48.
28. Heinegard D, Saxne T. Macromolecular markers in joint disease. J Rheumatol Suppl 1991; 27: 27-29.
29. Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 1993; 36: 1214-1222.
30. Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005; 434: 644-648.
31. Stanton H, Rogerson FM, East CJ, et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005; 434: 648-652.
32. Neuhold LA, Killar L, Zhao W, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001; 107: 35-44.
33. Hirata M, Kugimiya F, Fukai A, et al. C/EBPbeta and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2alpha as the inducer in chondrocytes. Hum Mol Genet 2012; 21: 1111-1123.
34. Saito T, Fukai A, Mabuchi A, et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010; 16: 678-686.
35. Tamiya H, Ikeda T, Jeong JH, et al. Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene 2008; 416: 53-60.
36. Gospodarowicz D, Mescher AL. A comparison of the responses of cultured myoblasts and chondrocytes to fibroblast and epidermal growth factors. J Cell Physiol 1977; 93: 117-127.
37. Kato Y, Gospodarowicz D. Growth requirements of low-density rabbit costal chondrocyte cultures maintained in serum-free medium. J Cell Physiol 1984; 120: 354-363.
38. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46: 2648-2657.
39. Flannelly J, Chambers MG, Dudhia J, et al. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ortmodel of osteoarthritis. Osteoarthritis Cartilage 2002; 10: 722-733.
40. Kevorkian L, Young DA, Darrah C, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 50: 131-141.
41. Yang S, Kim J, Ryu JH, et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010; 16: 687-693.
42. Majumdar MK, Askew R, Schelling S, et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007; 56: 3670-3674.